Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 10 points (-0.1%) at 13,082 as of Monday, Nov. 5, 2012, 1:34 PM ET. The NYSE advances/declines ratio sits at 1,351 issues advancing vs. 1,574 declining with 129 unchanged. The Health Services industry currently sits up 0.2% versus the S&P 500, which is down 0.1%. Top gainers within the industry include Health Net ( HNT), up 12.5%, and Boston Scientific ( BSX), up 1.7%. TheStreet Ratings group would like to highlight 5 stocks pushing the industry higher today: 5. Varian Medical Systems ( VAR) is one of the companies pushing the Health Services industry higher today. As of noon trading, Varian Medical Systems is up $0.45 (0.6%) to $70.60 on heavy volume Thus far, 1.6 million shares of Varian Medical Systems exchanged hands as compared to its average daily volume of 969,400 shares. The stock has ranged in price between $69.45-$71.39 after having opened the day at $69.78 as compared to the previous trading day's close of $70.15. Varian Medical Systems, Inc. designs, manufactures, sells, and services equipment and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy, stereotactic radiosurgery, and brachytherapy worldwide. Varian Medical Systems has a market cap of $7.6 billion and is part of the health care sector. The company has a P/E ratio of 18.3, above the S&P 500 P/E ratio of 17.7. Shares are up 2.4% year to date as of the close of trading on Friday. Currently there are 8 analysts that rate Varian Medical Systems a buy, no analysts rate it a sell, and 2 rate it a hold. TheStreet Ratings rates Varian Medical Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and increase in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Varian Medical Systems Ratings Report now.